VentriPoint Diagnostics Ltd creates diagnostic tools to monitor patients with heart diseases, a leading cause of death in developed countries. Using data from existing medical imaging devices, the VentriPoint Diagnostic System generates heart measurements in a rapid manner. VentriPoint Diagnostics Ltd is a publicly traded company with operations based in Seattle, is the result of a 2007 merger between VentriPoint, Inc. and Luca Capital Inc. The company’s service creates critical information from existing medical imaging equipment using patented and proprietary methods incorporating algorithms and the VentriPoint Knowledge Base. The VentriPoint Diagnostic System allows medical professionals to accurately create three-dimensional models that provide important shape and volume measurements of the right and left ventricles in only minutes more than the time needed for a routine echocardiogram. VentriPoint will deliverthese critical measurements via a Web-based service for a transactional fee.